I think MC is roughly 2 x cash position. However, to think of tens of millions in private and public funding which has been spent to get to this drug to the point of commencing phase 2 trials means it may be undervalued.
Ann: AMP945 Shows Efficacy in Model of Lung Fibrosis, page-11
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
